4//SEC Filing
Cheung Sylvia 4
Accession 0001171843-19-007390
CIK 0000898437other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:40 PM ET
Size
11.1 KB
Accession
0001171843-19-007390
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Stock Appreciation Rights
2019-11-06−35,000→ 0 totalExercise: $6.36Exp: 2020-01-26→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2019-11-06$6.36/sh+35,000$222,600→ 71,422 total - Sale
Common Stock
2019-11-08$59.71/sh−20,000$1,194,200→ 47,741 total - Tax Payment
Common Stock
2019-11-06$60.48/sh−3,681$222,627→ 67,741 total
Footnotes (3)
- [F1]On November 6, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung exercised stock appreciation rights ("SARS") granted on January 26, 2010 vesting in four equal annual installments beginning January 26, 2011 and expiring on January 26, 2020.
- [F2]Reflects 3,681 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 6, 2019.
- [F3]On November 8, 2019, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on May 7, 2019, Ms. Cheung sold 20,000 shares in multiple trades ranging from $59.00 to $60.40, a portion of which sale covered the tax liability associated with the SARs exercise. The price reported above reflects the weighted average sale price. Ms. Cheung undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001572857
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 5:40 PM ET
- Size
- 11.1 KB